The diagnostic value of somatostatin receptor scintigraphy (SRS) in detecting tumors has been assessed in a number of studies. We present a 30-year-old female with a history of eight months cough and left shoulder pain. Radiologic evaluation showed pulmonary mass and hepatic lesions, which were pathologically diagnosed as neuroendocrine carcinoma. 99mTc-octreotide scan demonstrated that the pulmonary lesion was positive for somatostatin receptor (SSTR), while the liver metastases were SSTR negative. The present case highlights the significance of a differential uptake pattern by somatostatin receptors in SRS in patients with neuroendocrine tumor
Somatostatin receptor scintigraphy (SRS) has become a routine imaging method for the diagnostics of ...
Objective: We aimed to evaluate the value of somatostatin receptor imaging (SRI) with In-111 octreot...
After the intravenous administration of a radiolabeled somatostatin analogue (octreotide), normal th...
In 80% to 90% of patients with carcinoids, tumor sites can be detected with [111In-DTPA-D-Phe1]-octr...
Peptide receptor scintigraphy is more sensitive at the biological than anatomical level, in contrast...
Liver metastases from neuroendocrine tumours frequently occur and significantly worsen their prognos...
Various tumours, classically specified as either neuroendocrine or non-neuroendocrine, contain high ...
The somatostatin (SS) receptor scintigraphy (SRS), using octreotide radiolabelled with111In (Ocreosc...
Abstract. In 80 % to 90 % of patients with carcinoids, tumor sites can be detected with [111In-DTPA-...
The use of somatostatin (SS) analogues in humans takes advantage by the availability of many related...
Somatostatin receptor scintigraphy (SRS) has become a routine imaging method for the diagnostics of ...
Objective: To study the ability of somatostatin receptor scintigraphy using Tc-99m-hydrazinonicotiny...
A 62-year-old woman with a history of abdominal pain presented with multiple hepatic lesions and dil...
Somatostatin-receptor (SS-R) scintigraphy successfully shows primary cancers and distant metastases ...
Tyr-3-Octreotide is a synthetic derivative of somatostatin and a somatostatin-receptor analogue. The...
Somatostatin receptor scintigraphy (SRS) has become a routine imaging method for the diagnostics of ...
Objective: We aimed to evaluate the value of somatostatin receptor imaging (SRI) with In-111 octreot...
After the intravenous administration of a radiolabeled somatostatin analogue (octreotide), normal th...
In 80% to 90% of patients with carcinoids, tumor sites can be detected with [111In-DTPA-D-Phe1]-octr...
Peptide receptor scintigraphy is more sensitive at the biological than anatomical level, in contrast...
Liver metastases from neuroendocrine tumours frequently occur and significantly worsen their prognos...
Various tumours, classically specified as either neuroendocrine or non-neuroendocrine, contain high ...
The somatostatin (SS) receptor scintigraphy (SRS), using octreotide radiolabelled with111In (Ocreosc...
Abstract. In 80 % to 90 % of patients with carcinoids, tumor sites can be detected with [111In-DTPA-...
The use of somatostatin (SS) analogues in humans takes advantage by the availability of many related...
Somatostatin receptor scintigraphy (SRS) has become a routine imaging method for the diagnostics of ...
Objective: To study the ability of somatostatin receptor scintigraphy using Tc-99m-hydrazinonicotiny...
A 62-year-old woman with a history of abdominal pain presented with multiple hepatic lesions and dil...
Somatostatin-receptor (SS-R) scintigraphy successfully shows primary cancers and distant metastases ...
Tyr-3-Octreotide is a synthetic derivative of somatostatin and a somatostatin-receptor analogue. The...
Somatostatin receptor scintigraphy (SRS) has become a routine imaging method for the diagnostics of ...
Objective: We aimed to evaluate the value of somatostatin receptor imaging (SRI) with In-111 octreot...
After the intravenous administration of a radiolabeled somatostatin analogue (octreotide), normal th...